CORE--ANIMAL BARRIER FACILITY

核心——动物屏障设施

基本信息

  • 批准号:
    6395585
  • 负责人:
  • 金额:
    $ 10.11万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1999
  • 资助国家:
    美国
  • 起止时间:
    1999-08-01 至 2000-07-31
  • 项目状态:
    已结题

项目摘要

The goal of the University of Chicago Cancer Research Center (UCCRC) Animal Barrier Facilities is to provide Cancer Center members the ability to conduct studies with rodents free of intercurrent infection with adventitious murine pathogens. The Barriers are supported by the facilities, programs, and staff of the University's Animal Resources Center (ARC). The ARC's Comparative Diagnostic Laboratory(CDL) provides expertise in rodent serology, microbiology, parasitology, and hematology. All biological materials introduced into rodents maintained in these facilities are evaluated by the CDL for contamination with adventitious viruses and mycoplasma by MAP testing. The ARC conducts an extensive Murine Health Monitoring Program to confirm that the pathogen-free status of the barrier colonies are maintained. The program is designed to detect variance in health status at specific time intervals. The program employs sentinel animals monitored monthly, serum banking, evaluation of "index" cases and close communication with investigative staff who may note unexplained variances in their experiments. Additionally, a quarantine program which includes extensive diagnostic evaluation is instituted for all rodents imported from colonies obtained from non-commercial vendors. Quarantine is essential to minimize the likelihood of introducing unwanted murine pathogens into barrier colonies. The rodent barrier facilities serving the UCCRC are located on the top floor of the Franklin McLean Institute (FMI) and in the basement of Biological Sciences Learning Center (BSLC). They are essential components of the Cancer Research Center, providing approximately 7,925 net square feet of animal holding and procedure space. The facilities contain sixteen animal holding rooms, seven of which are equipped with three Illinois cubicles. In addition to animal holding rooms, the barriers are equipped with laboratory and procedure space. Isolator type caging systems are employed throughout the barriers. All caging materials and feed are autoclaved prior to use. Animals are transferred within a separate hood or within a cubicle by animal care specialists, using chemically disinfected forceps between cage transfers. A maximum of four or five mice, dependent on weight, are permitted per cage. A bar coded cage card provides encrypted information including the strain or stock, source, and investigator. Cage cards are routinely scanned for information which is downloaded into the ARC database that is used to maintain accurate and detailed census information.
芝加哥大学癌症研究中心(UCCRC)

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JEFFREY A BLUESTONE其他文献

JEFFREY A BLUESTONE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JEFFREY A BLUESTONE', 18)}}的其他基金

Designer Tregs for restoring tolerance in patients with type 1 diabetes
用于恢复 1 型糖尿病患者耐受性的设计 Tregs
  • 批准号:
    9459191
  • 财政年份:
    2017
  • 资助金额:
    $ 10.11万
  • 项目类别:
Project 2 - Specificity and repertoire of Tregs in T1D
项目 2 - T1D 中 Tregs 的特异性和全部功能
  • 批准号:
    9151389
  • 财政年份:
    2016
  • 资助金额:
    $ 10.11万
  • 项目类别:
Donor-Alloantigen-Reactive Regulatory T Cell Therapy in Liver Transplantation
肝移植中供体同种异体抗原反应性调节性 T 细胞治疗
  • 批准号:
    8672260
  • 财政年份:
    2014
  • 资助金额:
    $ 10.11万
  • 项目类别:
Role of Innate Lymphoid Cells in Autoimmunity
先天淋巴细胞在自身免疫中的作用
  • 批准号:
    8637675
  • 财政年份:
    2013
  • 资助金额:
    $ 10.11万
  • 项目类别:
"Donor-Specific Regulatory T Cell Therapy in Liver Transplantation"
“肝移植中供体特异性调节性 T 细胞治疗”
  • 批准号:
    8728396
  • 财政年份:
    2012
  • 资助金额:
    $ 10.11万
  • 项目类别:
"Donor-Specific Regulatory T Cell Therapy in Liver Transplantation"
“肝移植中供体特异性调节性 T 细胞治疗”
  • 批准号:
    8264452
  • 财政年份:
    2012
  • 资助金额:
    $ 10.11万
  • 项目类别:
Spontaneous Autoimmune Model of Peripheral Neuropathy
周围神经病变的自发性自身免疫模型
  • 批准号:
    8116742
  • 财政年份:
    2010
  • 资助金额:
    $ 10.11万
  • 项目类别:
"Expanding beta-cell mass"
“扩大β细胞量”
  • 批准号:
    7994038
  • 财政年份:
    2010
  • 资助金额:
    $ 10.11万
  • 项目类别:
"Expanding beta-cell mass"
“扩大β细胞量”
  • 批准号:
    8322756
  • 财政年份:
    2010
  • 资助金额:
    $ 10.11万
  • 项目类别:
"Expanding beta-cell mass"
“扩大β细胞量”
  • 批准号:
    8143503
  • 财政年份:
    2010
  • 资助金额:
    $ 10.11万
  • 项目类别:

相似海外基金

BIOMEDICAL FACILITY
生物医学设施
  • 批准号:
    3819816
  • 财政年份:
  • 资助金额:
    $ 10.11万
  • 项目类别:
BIOMEDICAL FACILITY
生物医学设施
  • 批准号:
    4691285
  • 财政年份:
  • 资助金额:
    $ 10.11万
  • 项目类别:
BIOMEDICAL FACILITY
生物医学设施
  • 批准号:
    3815902
  • 财政年份:
  • 资助金额:
    $ 10.11万
  • 项目类别:
BIOMEDICAL FACILITY EQUIPMENT
生物医学设施设备
  • 批准号:
    3931637
  • 财政年份:
  • 资助金额:
    $ 10.11万
  • 项目类别:
BIOMEDICAL FACILITY
生物医学设施
  • 批准号:
    3961763
  • 财政年份:
  • 资助金额:
    $ 10.11万
  • 项目类别:
BIOMEDICAL FACILITY
生物医学设施
  • 批准号:
    3811789
  • 财政年份:
  • 资助金额:
    $ 10.11万
  • 项目类别:
BIOMEDICAL FACILITY
生物医学设施
  • 批准号:
    3937887
  • 财政年份:
  • 资助金额:
    $ 10.11万
  • 项目类别:
BIOMEDICAL FACILITY
生物医学设施
  • 批准号:
    4690608
  • 财政年份:
  • 资助金额:
    $ 10.11万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了